The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
OTC Drug-Global Market Insights and Sales Trends 2025
Synopsis
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
The global OTC Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of OTC Drug in various end use industries. The expanding demands from the Hospital, Clinic and Household,, are propelling OTC Drug market. Class A OTC Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Class B OTC Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for OTC Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global OTC Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global OTC Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, OTC Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of OTC Drug covered in this report include Bayer HealthCare, GlaxoSmithKline(GSK), Johnson&Johnson, Pfizer, Sanofi, AstraZeneca, BioGaia, Bristol Myers Squibb and Bukwang Pharmaceutica, etc.
The global OTC Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer HealthCare
GlaxoSmithKline(GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Global OTC Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global OTC Drug market, Segment by Type:
Class A OTC Drug
Class B OTC Drug
Global OTC Drug market, by Application
Hospital
Clinic
Household
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of OTC Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
The global OTC Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of OTC Drug in various end use industries. The expanding demands from the Hospital, Clinic and Household,, are propelling OTC Drug market. Class A OTC Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Class B OTC Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for OTC Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global OTC Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global OTC Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, OTC Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of OTC Drug covered in this report include Bayer HealthCare, GlaxoSmithKline(GSK), Johnson&Johnson, Pfizer, Sanofi, AstraZeneca, BioGaia, Bristol Myers Squibb and Bukwang Pharmaceutica, etc.
The global OTC Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer HealthCare
GlaxoSmithKline(GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Global OTC Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global OTC Drug market, Segment by Type:
Class A OTC Drug
Class B OTC Drug
Global OTC Drug market, by Application
Hospital
Clinic
Household
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of OTC Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of OTC Drug
1.1 OTC Drug Market Overview
1.1.1 OTC Drug Product Scope
1.1.2 OTC Drug Market Status and Outlook
1.2 Global OTC Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global OTC Drug Market Size by Region (2018-2029)
1.4 Global OTC Drug Historic Market Size by Region (2018-2023)
1.5 Global OTC Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, OTC Drug Market Size (2018-2029)
1.6.1 North America OTC Drug Market Size (2018-2029)
1.6.2 Europe OTC Drug Market Size (2018-2029)
1.6.3 Asia-Pacific OTC Drug Market Size (2018-2029)
1.6.4 Latin America OTC Drug Market Size (2018-2029)
1.6.5 Middle East & Africa OTC Drug Market Size (2018-2029)
2 OTC Drug Market by Type
2.1 Introduction
2.1.1 Class A OTC Drug
2.1.2 Class B OTC Drug
2.2 Global OTC Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global OTC Drug Historic Market Size by Type (2018-2023)
2.2.2 Global OTC Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America OTC Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe OTC Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific OTC Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America OTC Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa OTC Drug Revenue Breakdown by Type (2018-2029)
3 OTC Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Household
3.2 Global OTC Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global OTC Drug Historic Market Size by Application (2018-2023)
3.2.2 Global OTC Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America OTC Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe OTC Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific OTC Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America OTC Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa OTC Drug Revenue Breakdown by Application (2018-2029)
4 OTC Drug Competition Analysis by Players
4.1 Global OTC Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in OTC Drug as of 2022)
4.3 Date of Key Players Enter into OTC Drug Market
4.4 Global Top Players OTC Drug Headquarters and Area Served
4.5 Key Players OTC Drug Product Solution and Service
4.6 Competitive Status
4.6.1 OTC Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer HealthCare
5.1.1 Bayer HealthCare Profile
5.1.2 Bayer HealthCare Main Business
5.1.3 Bayer HealthCare OTC Drug Products, Services and Solutions
5.1.4 Bayer HealthCare OTC Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer HealthCare Recent Developments
5.2 GlaxoSmithKline(GSK)
5.2.1 GlaxoSmithKline(GSK) Profile
5.2.2 GlaxoSmithKline(GSK) Main Business
5.2.3 GlaxoSmithKline(GSK) OTC Drug Products, Services and Solutions
5.2.4 GlaxoSmithKline(GSK) OTC Drug Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline(GSK) Recent Developments
5.3 Johnson&Johnson
5.3.1 Johnson&Johnson Profile
5.3.2 Johnson&Johnson Main Business
5.3.3 Johnson&Johnson OTC Drug Products, Services and Solutions
5.3.4 Johnson&Johnson OTC Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer OTC Drug Products, Services and Solutions
5.4.4 Pfizer OTC Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi OTC Drug Products, Services and Solutions
5.5.4 Sanofi OTC Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca OTC Drug Products, Services and Solutions
5.6.4 AstraZeneca OTC Drug Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 BioGaia
5.7.1 BioGaia Profile
5.7.2 BioGaia Main Business
5.7.3 BioGaia OTC Drug Products, Services and Solutions
5.7.4 BioGaia OTC Drug Revenue (US$ Million) & (2018-2023)
5.7.5 BioGaia Recent Developments
5.8 Bristol Myers Squibb
5.8.1 Bristol Myers Squibb Profile
5.8.2 Bristol Myers Squibb Main Business
5.8.3 Bristol Myers Squibb OTC Drug Products, Services and Solutions
5.8.4 Bristol Myers Squibb OTC Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Bristol Myers Squibb Recent Developments
5.9 Bukwang Pharmaceutica
5.9.1 Bukwang Pharmaceutica Profile
5.9.2 Bukwang Pharmaceutica Main Business
5.9.3 Bukwang Pharmaceutica OTC Drug Products, Services and Solutions
5.9.4 Bukwang Pharmaceutica OTC Drug Revenue (US$ Million) & (2018-2023)
5.9.5 Bukwang Pharmaceutica Recent Developments
5.10 Chr. Hansen
5.10.1 Chr. Hansen Profile
5.10.2 Chr. Hansen Main Business
5.10.3 Chr. Hansen OTC Drug Products, Services and Solutions
5.10.4 Chr. Hansen OTC Drug Revenue (US$ Million) & (2018-2023)
5.10.5 Chr. Hansen Recent Developments
5.11 Cipla
5.11.1 Cipla Profile
5.11.2 Cipla Main Business
5.11.3 Cipla OTC Drug Products, Services and Solutions
5.11.4 Cipla OTC Drug Revenue (US$ Million) & (2018-2023)
5.11.5 Cipla Recent Developments
5.12 CoLucid
5.12.1 CoLucid Profile
5.12.2 CoLucid Main Business
5.12.3 CoLucid OTC Drug Products, Services and Solutions
5.12.4 CoLucid OTC Drug Revenue (US$ Million) & (2018-2023)
5.12.5 CoLucid Recent Developments
5.13 Daiichi Sankyo
5.13.1 Daiichi Sankyo Profile
5.13.2 Daiichi Sankyo Main Business
5.13.3 Daiichi Sankyo OTC Drug Products, Services and Solutions
5.13.4 Daiichi Sankyo OTC Drug Revenue (US$ Million) & (2018-2023)
5.13.5 Daiichi Sankyo Recent Developments
5.14 Friggs
5.14.1 Friggs Profile
5.14.2 Friggs Main Business
5.14.3 Friggs OTC Drug Products, Services and Solutions
5.14.4 Friggs OTC Drug Revenue (US$ Million) & (2018-2023)
5.14.5 Friggs Recent Developments
5.15 DSM
5.15.1 DSM Profile
5.15.2 DSM Main Business
5.15.3 DSM OTC Drug Products, Services and Solutions
5.15.4 DSM OTC Drug Revenue (US$ Million) & (2018-2023)
5.15.5 DSM Recent Developments
5.16 Eisai
5.16.1 Eisai Profile
5.16.2 Eisai Main Business
5.16.3 Eisai OTC Drug Products, Services and Solutions
5.16.4 Eisai OTC Drug Revenue (US$ Million) & (2018-2023)
5.16.5 Eisai Recent Developments
5.17 Eli Lilly
5.17.1 Eli Lilly Profile
5.17.2 Eli Lilly Main Business
5.17.3 Eli Lilly OTC Drug Products, Services and Solutions
5.17.4 Eli Lilly OTC Drug Revenue (US$ Million) & (2018-2023)
5.17.5 Eli Lilly Recent Developments
5.18 Herbalife
5.18.1 Herbalife Profile
5.18.2 Herbalife Main Business
5.18.3 Herbalife OTC Drug Products, Services and Solutions
5.18.4 Herbalife OTC Drug Revenue (US$ Million) & (2018-2023)
5.18.5 Herbalife Recent Developments
5.19 Euradite
5.19.1 Euradite Profile
5.19.2 Euradite Main Business
5.19.3 Euradite OTC Drug Products, Services and Solutions
5.19.4 Euradite OTC Drug Revenue (US$ Million) & (2018-2023)
5.19.5 Euradite Recent Developments
6 North America
6.1 North America OTC Drug Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe OTC Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific OTC Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America OTC Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa OTC Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 OTC Drug Market Dynamics
11.1 OTC Drug Industry Trends
11.2 OTC Drug Market Drivers
11.3 OTC Drug Market Challenges
11.4 OTC Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
